Corvus Pharmaceuticals, Inc.
Total Trades
12
Buys
10
Sells
2
Largest Trade
$1M+
Insiders
6
Institutional Funds
93
Inst. Value
$1M+
Activist Filings
26
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Director | SELL | $1M+ | 1.2M | $4.16 | Jul 2, 2025 |
| Thompson Peter A. | Director | SELL | $1M+ | 1.2M | $4.16 | Jul 2, 2025 |
| Grais Linda | Director | BUY | $15K–$50K | 10K | $2.45 | May 16, 2023 |
| Jones William Benton | See Remarks | BUY | $15K–$50K | 20K | $0.79 | Dec 20, 2022 |
| LEA LEIV | CFO | BUY | $15K–$50K | 34K | $0.75 | Dec 15, 2022 |
| MILLER RICHARD A MD | President and CEO | BUY | $15K–$50K | 60K | $0.75 | Dec 15, 2022 |
| MILLER RICHARD A MD | President and CEO | BUY | $15K–$50K | 25K | $0.76 | Sep 28, 2022 |
| MILLER RICHARD A MD | President and CEO | BUY | $15K–$50K | 20K | $0.81 | Sep 20, 2022 |
| MILLER RICHARD A MD | President and CEO | BUY | $1K–$15K | 10K | $1.01 | Jun 28, 2022 |
| MILLER RICHARD A MD | President and CEO | BUY | $15K–$50K | 15K | $1.64 | Apr 1, 2022 |
| LEA LEIV | CFO | BUY | $50K–$100K | 49K | $1.57 | Mar 17, 2022 |
| MILLER RICHARD A MD | President and CEO | BUY | $15K–$50K | 30K | $1.49 | Mar 17, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 93 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 7.2M | $1M+ | SH |
| ADAMS STREET PARTNERS LLC | 3.3M | $1M+ | SH |
| Point72 Asset Management, L.P. | 2.9M | $1M+ | SH |
| STATE STREET CORP | 2.8M | $1M+ | SH |
| MPM BioImpact LLC | 2.7M | $1M+ | SH |
| Vivo Capital, LLC | 2.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $1M+ | SH |
| DCF Advisers, LLC | 729K | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 692K | $1M+ | SH |
| Logos Global Management LP | 500K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 466K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 466K | $1M+ | SH |
| SPHERA FUNDS MANAGEMENT LTD. | 408K | $1M+ | SH |
| BARCLAYS PLC | 395K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 292K | $1M+ | SH |
| BlackRock, Inc. | 235K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 171K | $1M+ | SH |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 167K | $1M+ | SH |
| TOWERVIEW LLC | 140K | $1M+ | SH |
| Squarepoint Ops LLC | 105K | $500K+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 13, 2026
7.8%
6.1M shares
SC 13D/A · Feb 5, 2026
3.9%
3.3M shares
SC 13G · Jan 30, 2026
5.2%
3.9M shares
SC 13D/A · Jan 28, 2026
10.3%
8.6M shares
SC 13G · Oct 17, 2025
5.4%
4.0M shares
SC 13G/A · Aug 14, 2025
0.0%
0 shares
SC 13G/A · May 15, 2025
6.0%
4.1M shares
SC 13D/A · May 15, 2025
12.2%
9.8M shares
SC 13D/A · May 2, 2025
13.8%
9.8M shares
SC 13G/A · Feb 14, 2025
9.8%
6.7M shares
SC 13G/A · Feb 13, 2025
7.7%
5.2M shares
SC 13G/A · Aug 2, 2024
10.0%
6.3M shares
SC 13G/A · May 13, 2024
10.0%
6.3M shares
Point72 Asset Management, L.P.
SC 13G · May 9, 2024
9.9%
17.1M shares
SC 13D/A · May 8, 2024
11.1%
6.9M shares
SC 13G · Feb 14, 2024
5.1%
2.5M shares
SC 13G/A · Feb 13, 2024
7.2%
3.7M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G · Feb 13, 2023
5.1%
2.4M shares
SC 13G/A · Feb 10, 2023
6.5%
3.1M shares
Integrated Core Strategies (US) LLC
SC 13G/A · Jan 30, 2023
4.1%
1.9M shares
Venrock Healthcare Capital Partners II, L.P.
SC 13G/A · Feb 14, 2022
0.5%
250K shares
SC 13G/A · Feb 14, 2022
6.7%
3.1M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 12, 2022
1.6%
730K shares
SC 13G/A · Feb 11, 2022
5.5%
2.6M shares
Integrated Core Strategies (US) LLC
SC 13G/A · Jan 18, 2022
4.8%
2.2M shares